Key result
Citation count and media impact score analysis identified the top 10 and 10 outstanding Asian cardiovascular research articles published in 2023.
Answers are grounded in this paper and cite their sources.
This perspective highlights the top 20 high-impact cardiovascular research articles from 2023 focused on Asian populations or led by Asian investigators, including advances in machine learning for CAD and lipid-lowering strategies.
T he year 2023 has witnessed a thriving of research in the Asian cardiovascular field.With nourishment from the Asian wisdom, JACC: Asia has entered its third year since its inaugural issue.To fill in the blank of the Asianpopulation-focused cardiovascular problem, various clinical scientists from Asia worked on randomized clinical trials, cohort studies, and registries, as well as cross-disciplinary translational medicine and cutting-edge technology.There have been significant advancements in the field of cardiovascular research in Asia, as exemplified by the 10 papers chosen for this perspective.To identify the top 10 papers in Asian cardiovascular research, we systematically analyzed the citation count and media impact score of original research articles from Asian authors in the cardiovascular field, sourced from prestigious journals such as New England Journal of Medicine, JAMA, Lancet, JAMA Cardiology, Circulation, Journal of the American College of Cardiology, and European Heart Journal.Our selection criteria focused on studies involving Asian population cohorts and those led by teams of Asian researchers.The overall score, which incorporated both citation and media exposure metrics, was adjusted for publication date.Subsequently, all editorial board members collectively voted to determine the top 10 articles from the highest-scoring 20.The results of the Top 10 Asian Cardiovascular Research Selection for the year 2023 are shown in Table 1.In addition, 10 other articles from the highest-scoring 20 were honored as outstanding research in the field of Asian cardiovascular medicine for the year 2023.Please refer to Table 2 for details.CORONARY ARTERY DISEASE Severity and mortality risk prediction for patients with coronary artery disease (CAD) is always a pragmatic clinical interest.Some Asian American researchers have developed and validated a CAD-predictive machine learning model using electronic health records from BioMe and UK Biobank, the in silico scores for CAD. 1 Using machine learningbased quantitative markers for CAD may aid in characterizing the disease state and predicting clinical outcomes in patients, thereby enhancing disease detection and reducing instances of underdiagnosis.Other than prognosis prediction, lipid-lowering treatment is a mainstay in secondary prevention of CAD.The LODESTAR (Low-Density Lipoprotein Cholesterol-Targeting Statin Therapy Versus Intensity-Based Statin Therapy in Patients With Coronary Artery Disease) trial in South Korea was a head-to-head comparison of the effectiveness of the high-intensity statin treatment (a 50% reduction in low-density lipoprotein cholesterol [LDL-C]) and the treat-to-target statin treatment (titrate to a specific LDL-C goal). 2 The study demonstrates that the treatto-target strategy was noninferior to the highintensity statin strategy for the primary endpoint, with comparable rates of major adverse cardiac and cerebrovascular events in both groups.The treat-totarget strategy might enable a personalized approach that takes into account individual variations in drug response to statin therapy.A subgroup analysis of the diabetic cohort in the RACING (Randomized Comparison of Efficacy and Safety of Lipid-Lowering With Statin Monotherapy Versus Statin/ Ezetimibe Combination for High-risk Cardiovascular Diseases) trial showed that combination therapy with
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) conducted a review in Cardiovascular disease in Asian populations. Citation count and media impact score analysis identified the top 10 and 10 outstanding Asian cardiovascular research articles published in 2023.
Synapse has enriched 10 related papers. Consider them for comparative context: